Small Molecule Modulators of Histone Acetyltransferase P300
Overview
Affiliations
Histone acetyltransferases (HATs) are a group of enzymes that play a significant role in the regulation of gene expression. These enzymes covalently modify the N-terminal lysine residues of histones by the addition of acetyl groups from acetyl-CoA. Dysfunction of these enzymes is often associated with the manifestation of several diseases, predominantly cancer. Here we report that anacardic acid from cashew nut shell liquid is a potent inhibitor of p300 and p300/CBP-associated factor histone acetyltranferase activities. Although it does not affect DNA transcription, HAT-dependent transcription from a chromatin template was strongly inhibited by anacardic acid. Furthermore, we describe the design and synthesis of an amide derivative N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide (CTPB) using anacardic acid as a synthon, which remarkably activates p300 HAT activity but not that of p300/CBP-associated factor. Although CTPB does not affect DNA transcription, it enhances the p300 HAT-dependent transcriptional activation from in vitro assembled chromatin template. However, it has no effect on histone deacetylase activity. These compounds would be useful as biological switching molecules for probing into the role of p300 in transcriptional studies and may also be useful as new chemical entities for the development of anticancer drugs.
Dysregulation of the p300/CBP histone acetyltransferases in human cancer.
Xu L, Xuan H, Shi X Epigenomics. 2025; 17(3):193-208.
PMID: 39929233 PMC: 11812348. DOI: 10.1080/17501911.2024.2447807.
Wang Y, Li C, Huang J, Zeng Q, Li L, Yang P Foods. 2025; 14(2).
PMID: 39856898 PMC: 11765268. DOI: 10.3390/foods14020232.
Wu X, Zhang X, Tang S, Wang Y Cell Biol Toxicol. 2025; 41(1):32.
PMID: 39825161 PMC: 11742294. DOI: 10.1007/s10565-024-09984-0.
Swain N, Zheng Y Chembiochem. 2024; 26(1):e202400692.
PMID: 39576250 PMC: 11737044. DOI: 10.1002/cbic.202400692.
Huang C, Awad M, Gal-Tanamy M, Yu M Clin Mol Hepatol. 2024; 30(3):326-344.
PMID: 38665034 PMC: 11261227. DOI: 10.3350/cmh.2024.0155.